Brazil authorizes Pfizer vaccine for children aged 12 and older
Studies were conducted abroad and assessed by the Brazilian regulator
Published in 11/06/2021 - 14:08 By Agência Brasil - Brasília
Brazil’s national sanitary regulator Anvisa authorized the use of Pfizer’s Comirnaty vaccine for children aged 12 years old and older. The jab’s leaflet will now also include this age group.
The expansion was approved, Anvisa stated, after studies were unveiled by laboratories indicating the safety and efficiency of the vaccine for this group. The research was carried out overseas and assessed by the Brazilian watchdog.
Comirnaty is the only vaccine authorized in Brazil for people younger than 18. It was the first to receive definitive registration status as a vaccine against COVID-19 in the country.
Translation: Fabrício Ferreira - Edition: Kelly Oliveira / Nira Foster
Dê sua opinião sobre a qualidade do conteúdo que você acessou.
Para registrar sua opinião, copie o link ou o título do conteúdo e clique na barra de manifestação.
Você será direcionado para o "Fale com a Ouvidoria" da EBC e poderá nos ajudar a melhorar nossos serviços, sugerindo, denunciando, reclamando, solicitando e, também, elogiando.